Methadone serum concentrations and influencing factors: A naturalistic observational study-Reference-Cited by-同舟云学术

Methadone serum concentrations and influencing factors: A naturalistic observational study

Published:2019-05-28 Issue:11 Volume:236 Page:3159-3167
ISSN:0033-3158
Container-title:Psychopharmacology
language:en
Short-container-title:Psychopharmacology

Author:

Chalabianloo Fatemeh^ORCID,Westin Andreas A.,Skogvoll Eirik,Bramness Jørgen G.,Spigset Olav

Publisher

Springer Science and Business Media LLC

Subject

Pharmacology

Link

http://link.springer.com/content/pdf/10.1007/s00213-019-05277-1.pdf

Reference40 articles.

1. Alvarellos M, Guillemette C, Altman RB, Klein TE (2018) PharmGKB summary: atazanavir pathway, pharmacokinetics/pharmacodynamics. Pharmacogenet Genomics 28:127–137

2. Bart G (2012) Maintenance medication for opiate addiction: the foundation of recovery. J Addict Dis 31:207–225

3. Bjornsson TD, Callaghan JT, Einolf HJ, Fischer V, Gan L, Grimm S, Kao J, King SP, Miwa G, Ni L, Kumar G, McLeod J, Obach SR, Roberts S, Roe A, Shah A, Snikeris F, Sullivan JT, Tweedie D, Vega JM, Walsh J, Wrighton SA, Pharmaceutical Research and Manufacturers of America Drug Metabolism/Clinical Pharmacology Technical Working Groups (2003) The conduct of in vitro and in vivo drug-drug interaction studies: a PhRMA perspective. J Clin Pharmacol 43:443–469

4. Bruce RD, Moody DE, Altice FL, Gourevitch MN, Friedland GH (2013) A review of pharmacological interactions between HIV or hepatitis C virus medications and opioid agonist therapy: implications and management for clinical practice. Expert Rev Clin Pharmacol 6:249–269

5. Clarke SM, Mulcahy FM, Tjia J, Reynolds HE, Gibbons SE, Barry MG, Back DJ (2001) Pharmacokinetic interactions of nevirapine and methadone and guidelines for use of nevirapine to treat injection drug users. Clin Infect Dis 33:1595–1597

Cited by 7 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Effect on QTc interval by switching from methadone to equipotent R‐methadone dose in methadone maintenance treatment patients;Basic & Clinical Pharmacology & Toxicology;2024-02-03

2. Methadone pharmacokinetics in opioid agonist treatment: Influencing factors and clinical implications;Basic & Clinical Pharmacology & Toxicology;2024-01-15

3. Impact of liver fibrosis and clinical characteristics on dose-adjusted serum methadone concentrations;Journal of Addictive Diseases;2022-03-31

4. Add-On Selective Estrogen Receptor Modulators for Methadone Maintenance Treatment;Frontiers in Endocrinology;2021-08-05

5. Subjective symptoms and serum methadone concentrations: what should guide dose adjustments in methadone maintenance treatment? A naturalistic cohort study from Norway;Substance Abuse Treatment, Prevention, and Policy;2021-05-03